SOLANA BEACH, Calif., June 19, 2020 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the U.S. Food and Drug Administration (FDA)…Original Article
FDA Approves Gimoti (metoclopramide) Nasal Spray for Diabetic Gastroparesis
